189 related articles for article (PubMed ID: 36645690)
1. [Chemobrain - cognitive disorders after chemotherapy].
Kupryjaniuk A; Sobstyl M
Pol Merkur Lekarski; 2022 Dec; 50(300):398-400. PubMed ID: 36645690
[TBL] [Abstract][Full Text] [Related]
2. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
3. [Cognitive deficits with chemotherapy in women with breast cancer: a bibliographic revisión].
Arce B; Grañana N
Rev Fac Cien Med Univ Nac Cordoba; 2023 Jun; 80(2):126-133. PubMed ID: 37402295
[TBL] [Abstract][Full Text] [Related]
4. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.
Guran E; Hu J; Wefel JS; Chung C; Cata JP
Br J Anaesth; 2022 Dec; 129(6):909-922. PubMed ID: 36270848
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options.
Di Iulio F; Cravello L; Shofany J; Paolucci S; Caltagirone C; Morone G
Neurol Sci; 2019 Sep; 40(9):1759-1774. PubMed ID: 31049790
[TBL] [Abstract][Full Text] [Related]
6. Chemobrain: a systematic review of structural and functional neuroimaging studies.
Simó M; Rifà-Ros X; Rodriguez-Fornells A; Bruna J
Neurosci Biobehav Rev; 2013 Sep; 37(8):1311-21. PubMed ID: 23660455
[TBL] [Abstract][Full Text] [Related]
7. Cognitive deficits in bipolar disorders: Implications for emotion.
Lima IMM; Peckham AD; Johnson SL
Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
[TBL] [Abstract][Full Text] [Related]
8. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
9. Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review.
George RP; Semendric I; Hutchinson MR; Whittaker AL
Brain Behav Immun; 2021 May; 94():392-409. PubMed ID: 33516919
[TBL] [Abstract][Full Text] [Related]
10. [An overview of the research of cancer-related cognitive impairment].
Ferencz V; S Nagy Z; Tóth M
Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain.
El-Agamy SE; Abdel-Aziz AK; Esmat A; Azab SS
Cancer Chemother Pharmacol; 2019 Jul; 84(1):1-14. PubMed ID: 30955080
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-related cognitive impairment or « chemobrain »: concept and state of art.
Bompaire F; Durand T; Léger-Hardy I; Psimaras D; Ricard D
Geriatr Psychol Neuropsychiatr Vieil; 2017 Mar; 15(1):89-98. PubMed ID: 28266346
[TBL] [Abstract][Full Text] [Related]
13. [Cancer-related cognitive impairment in older adults].
Baratali L; Major K; Rouaud O; Draganski B
Rev Med Suisse; 2020 Nov; 16(714):2172-2175. PubMed ID: 33174700
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
15. Similar neurocognitive patterns in patients treated with lenalidomide: chemobrain effect?
Calvi E; Marchetti M; Santagata F; Luppi C; Coppo E; Massaia M; Isaia GC
Neurocase; 2019 Dec; 25(6):259-262. PubMed ID: 31522586
[No Abstract] [Full Text] [Related]
16. Neuropsychological functioning among patients with different types of cancer : Postchemotherapy cognitive impairment and implications for rehabilitation.
Megari K
Neuropsychiatr; 2021 Jun; 35(2):92-97. PubMed ID: 32274652
[TBL] [Abstract][Full Text] [Related]
17. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
[TBL] [Abstract][Full Text] [Related]
18. [Chemobrain].
Szentmartoni G; Makkos Z; Dank M
Neuropsychopharmacol Hung; 2018 Sep; 20(3):112-116. PubMed ID: 30459288
[TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases.
Nguyen LD; Ehrlich BE
EMBO Mol Med; 2020 Jun; 12(6):e12075. PubMed ID: 32346964
[TBL] [Abstract][Full Text] [Related]
20. Neural correlates of chemotherapy-related cognitive impairment.
Kaiser J; Bledowski C; Dietrich J
Cortex; 2014 May; 54():33-50. PubMed ID: 24632463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
